Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.

Abstract: The present invention relates to cough syrups containing ambroxol hydrochloride, characterised in that they are substantially free from glycerol, and their use for mucolytic treatment in acute and chronic diseases of the bronchi and/or lungs.

Abstract: The invention relates to a fast dissolving granulate obtainable by spray-dying of a composition comprising a dry methanolic or ethanolic extract of valerian root, a dry methanolic extract of hop strobiles, optionally a carrier, one or more artificial sweeteners, one or more flavoring agents, optionally an acidifier and water for the treatment of sleep disorders, wherein the said granulate is to be administered upon dissolution in water or an aqueous beverage shortly before bedtime.

Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.

Abstract: The present invention relates to aqueous compositions containing bromhexine, the composition comprising an amount of sugar alcohols of less than 10 g based on 100 ml of the composition, and the use thereof for secretolytic therapy in acute and chronic bronchopulmonary disorders.

Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.

Abstract: The present invention relates to aqueous compositions containing bromhexine, the composition comprising an amount of sugar alcohols of less than 10 g based on 100 ml of the composition, and the use thereof for secretolytic therapy in acute and chronic bronchopulmonary disorders.

Abstract: The present application relates to a process for preparing an extract of leaves of Vitis vinifera L. comprising the following steps: a) preparing a drug from leaves of Vitis vinifera L. b) extracting the drug with an eluant selected from among water and mixtures of water with alcohol, to obtain a raw extract, c) separating the raw extract from the extracted drug, d) at least partly eliminating the eluant, to obtain a thick extract, e) redissolving the thick extract in water, f) separating off any insoluble constituents, g) selectively concentrating secondary plant ingredients by i. a 2-phase extraction or ii. membrane filtration; the extract that is obtainable therefrom, pharmaceutical preparations containing this extract and the use thereof.

Abstract: Disclosed are sprayable compositions containing red vine leaf extract, which can be sprayed onto the skin using suitable spray devices.

Abstract: The invention relates to new indications for direct thrombin inhibitors such as dabigatran etexilate in the cardiovascular field.